Format

Send to

Choose Destination
See comment in PubMed Commons below
Toxicol Lett. 2009 Apr 10;186(1):58-61. doi: 10.1016/j.toxlet.2008.08.018. Epub 2008 Sep 7.

Comparison of the diagnostic performance of human whole genome microarrays using mixed-tissue RNA reference samples.

Author information

1
Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA. karol.thompson@fda.hhs.gov

Abstract

Universal approaches for assessing the diagnostic performance of microarray assays are essential for the application of microarray technology to clinical and regulatory settings. Reference systems for diagnostic assays in laboratory medicine typically involve the utilization of reference samples, metrics, and reference datasets to ensure that measurements are comparable and true. For microarray performance evaluation and process improvement, reference samples can be composed of mixes of different tissue or cell line RNAs that contain tissue-selective analytes at defined target ratios. The diagnostic accuracy of detected changes in expression, measured as the area under the curve from receiver-operating characteristic plots, can provide a single commutable value for comparing assay specificity and sensitivity. Examples of applying this method for assessing overall performance are provided using public datasets generated on five commercial human whole genome microarray platforms for the MicroArray Quality Control project, a community-wide effort to address issues surrounding microarray data reliability.

PMID:
18822358
DOI:
10.1016/j.toxlet.2008.08.018
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center